Valbiotis SA reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EUR 6.81 million compared to EUR 2.81 million a year ago. Net loss was EUR 7.37 million compared to EUR 12.31 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2 EUR | -5.21% | -48.59% | -60.00% |
Jun. 04 | Valbiotis Terminates Licensing, Supply Deal With Nestlé Unit | MT |
Jun. 04 | Valbiotis: share price plummets, Nestlé agreement terminated | CF |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-60.00% | 34.11M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- ALVAL Stock
- News VALBIOTIS
- Valbiotis SA Reports Earnings Results for the Full Year Ended December 31, 2023